Carnostatine hydrochloride

• CAT Number: I046019
• Molecular Formula: C10H17ClN4O4
• Molecular Weight: 292.72
• Purity: ≥95%
• Synonyms: (2S)-2-[[(2S)-4-amino-2-hydroxybutanoyl]amino]-3-(1H-imidazol-5-yl)propanoic acid;hydrochloride
• InChI: InChI=1S/C10H16N4O4.ClH/c11-2-1-8(15)9(16)14-7(10(17)18)3-6-4-12-5-13-6;/h4-5,7-8,15H,1-3,11H2,(H,12,13)(H,14,16)(H,17,18);1H/t7-,8-;/m0./s1
• InChIKey: DVOGVAYBGHFTIP-WSZWBAFRSA-N
• SMILES: C1=C(NC=N1)CC(C(=O)O)NC(=O)C(CCN)O.Cl

Carnostatine hydrochloride(CAT: I046019) is a potent and selective metalloproteinase inhibitor, widely recognized as an inhibitor of aminopeptidase B and leucine aminopeptidase. By blocking proteolytic activity, Carnostatine serves as a valuable biochemical tool for studying protein and peptide metabolism, protease-regulated signaling, and pathways linked to inflammation, immunity, and tissue remodeling. Its hydrochloride salt form enhances stability and solubility for laboratory use. Carnostatine hydrochloride is frequently applied in enzymology and biochemical assays to explore substrate specificity and protease regulation, providing researchers with a reliable compound for investigating aminopeptidase function in physiological and pathological processes.